SCHEMBL23529288

SCHEMBL23529288

CC(C)(C)OC(=O)N1CCN(Cc2cnn(Cc3ccccc3)c(=O)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 6/20 0.54
▸ MAPT P10636 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ ADORA2A P29274 1/20 0.48
▸ LMNA P02545 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ S1PR4 O95977 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ S1PR1 P21453 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ SCD O00767 1/20 0.47
▸ SCD5 Q86SK9 1/20 0.47
▸ VEGFA P15692 1/20 0.45
▸ EGLN1 Q9GZT9 1/20 0.45
▸ KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862442 0.84 ALDH1A1 (0.60) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL8210703 0.80 KMT2A (0.55) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL5569584 0.78 GPR119 (0.58) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL11932534 0.77 FAAH (0.57) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL6182303 0.77 ALDH1A1 (0.63) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL892981 0.77 ALDH1A1 (0.54) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL29132192 0.77 FNTA (0.52) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL23529286 0.76 OPRD1 (0.50) TP53MAPTTHRBALDH1A1VEGFA
SCHEMBL28105762 0.76 VEGFA (0.60) TP53MAPTTHRBLMNAALDH1A1
SCHEMBL2363123 0.76 VEGFA (0.56) TP53MAPTTHRBALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127273-A1 1 -((6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL)METHYL)PIPERAZINE AND 1 -((6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)PIPERAZINE DERIVATIVES AS PROLYL HYDROXYLASE, HIF-1 ALPHA AND PGK MODULATORS FOR USE IN TREATING INFLAMMATORY DISEASES, CANCER OR INFECTIONS GB004, INC. (US) 2021-06-24 — — WO disclosed
Send feedback